Part of the strategy of 20Med Therapeutics is to develop own products based on their proprietary nanogels for licensing in clinical development. However, 20Med’s nanogel technology for efficient intracellular drug delivery has much more commercial opportunities than we can develop independently. Therefore, 20Med Therapeutics is open for partnerships by providing drug delivery solutions to pharmaceutical and biotech companies in the development, evaluation and commercialization of new products incorporating partner's proprietary molecules in our delivery systems.

For more information about partnering opportunities and to learn more about 20Med’s drug delivery technologies, please contact us at